What We're Reading: Page 311
Industry reads hand-picked by our editors
Oct 10, 2016
-
Reuters
Bristol drug flop opens big cancer opportunity: AstraZeneca CEO
-
Renaissance Capital
Gene editing biotech CRISPR Therapeutics sets terms for $75 million IPO
-
SupplyChain Dive
Are pharmaceutical supply chains ill-regulated?
-
The Wall Street Journal
Insulin prices soar while drugmakers' share stays flat
Oct 07, 2016
-
BioWorld
European biopharma funding is down 43% so far this year
-
Stat
Whether it’s Trump or Clinton, biotech is in for ‘a moment of change’
-
Science
Why are people fighting over a promising treatment for a fatal childhood disease?
-
The Wall Street Journal
Pfizer to sell New York City headquarters by end of next year
Oct 06, 2016
Oct 05, 2016
Oct 04, 2016
Oct 03, 2016
-
The Wall Street Journal
Drugmakers point finger at middlemen for raising drug prices
-
Stat
Obama extends controversial program for rare pediatric drugs
-
C&EN
A silent liver disease epidemic
-
Reuters
Big Pharma vs Big Pharma in court battles over biosimilar drugs
-
New York Times
Tom Brokaw: Learning to live with cancer
Previous
